These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37753527)
21. MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68. Zhao D; Tian Y; Li P; Wang L; Xiao A; Zhang M; Shi T Mol Med Rep; 2015 Oct; 12(4):5554-60. PubMed ID: 26136151 [TBL] [Abstract][Full Text] [Related]
22. lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma. Yu Y; Chen F; Yang Y; Jin Y; Shi J; Han S; Chu P; Lu J; Tai J; Wang S; Yang W; Wang H; Guo Y; Ni X Int J Oncol; 2019 Jul; 55(1):93-102. PubMed ID: 31180520 [TBL] [Abstract][Full Text] [Related]
23. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma. Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279 [TBL] [Abstract][Full Text] [Related]
24. Label-free, high-throughput holographic screening and enumeration of tumor cells in blood. Singh DK; Ahrens CC; Li W; Vanapalli SA Lab Chip; 2017 Aug; 17(17):2920-2932. PubMed ID: 28718848 [TBL] [Abstract][Full Text] [Related]
25. Label-free multimodal nonlinear optical imaging of needle biopsy cores for intraoperative cancer diagnosis. Yang L; Park J; Chaney EJ; Sorrells JE; Marjanovic M; Phillips H; Spillman DR; Boppart SA J Biomed Opt; 2022 May; 27(5):. PubMed ID: 35643823 [TBL] [Abstract][Full Text] [Related]
26. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation. Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286 [TBL] [Abstract][Full Text] [Related]
27. Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma. Wylie LA; Hardwick LJ; Papkovskaia TD; Thiele CJ; Philpott A Dis Model Mech; 2015 May; 8(5):429-41. PubMed ID: 25786414 [TBL] [Abstract][Full Text] [Related]
28. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma. Mohammadi M; Goodarzi M; Jaafari MR; Mirzaei HR; Mirzaei H Cancer Gene Ther; 2016 Nov; 23(11):371-372. PubMed ID: 27740613 [TBL] [Abstract][Full Text] [Related]
29. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma. Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046 [TBL] [Abstract][Full Text] [Related]
30. Horizontal transfer of the stemness-related markers EZH2 and GLI1 by neuroblastoma-derived extracellular vesicles in stromal cells. Villasante A; Godier-Furnemont A; Hernandez-Barranco A; Coq JL; Boskovic J; Peinado H; Mora J; Samitier J; Vunjak-Novakovic G Transl Res; 2021 Nov; 237():82-97. PubMed ID: 34217898 [TBL] [Abstract][Full Text] [Related]
31. Lin28B and Let-7 in the Control of Sympathetic Neurogenesis and Neuroblastoma Development. Hennchen M; Stubbusch J; Abarchan-El Makhfi I; Kramer M; Deller T; Pierre-Eugene C; Janoueix-Lerosey I; Delattre O; Ernsberger U; Schulte JB; Rohrer H J Neurosci; 2015 Dec; 35(50):16531-44. PubMed ID: 26674877 [TBL] [Abstract][Full Text] [Related]
32. Exosomal hsa-piR1089 promotes proliferation and migration in neuroblastoma via targeting KEAP1. Wang H; Shi B; Zhang X; Shen P; He Q; Yin M; Pan Y; Ma J Pathol Res Pract; 2023 Jan; 241():154240. PubMed ID: 36436316 [TBL] [Abstract][Full Text] [Related]
33. Label-free discrimination and selection of cancer cells from blood during flow using holography-induced dielectrophoresis. Dudaie M; Nissim N; Barnea I; Gerling T; Duschl C; Kirschbaum M; Shaked NT J Biophotonics; 2020 Nov; 13(11):e202000151. PubMed ID: 32700785 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma. Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901 [TBL] [Abstract][Full Text] [Related]
35. The embryonic trunk neural crest microenvironment regulates the plasticity and invasion of human neuroblastoma via TrkB signaling. Kasemeier-Kulesa JC; Spengler JA; Muolo CE; Morrison JA; Woolley TE; Schnell S; Kulesa PM Dev Biol; 2021 Dec; 480():78-90. PubMed ID: 34416224 [TBL] [Abstract][Full Text] [Related]
36. Circulating tumor cells in neuroblastoma: Current status and future perspectives. Yang R; Zheng S; Dong R Cancer Med; 2023 Jan; 12(1):7-19. PubMed ID: 35632981 [TBL] [Abstract][Full Text] [Related]
37. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression. Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871 [TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma. Brignole C; Calarco E; Bensa V; Giusto E; Perri P; Ciampi E; Corrias MV; Astigiano S; Cilli M; Loo D; Bonvini E; Pastorino F; Ponzoni M J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37775116 [TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of copy number alterations by liquid biopsy for neuroblastoma. Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Ishiwata K; Yamada Y; Yoshida M; Yoshida K; Shioda Y; Kiyotani C; Terashima K; Tomizawa D; Takasugi N; Takita J; Miyazaki O; Kiyokawa N; Yoneda A; Kanamori Y; Hishiki T; Matsumoto K; Hata K; Yoshioka T; Kato M Genes Chromosomes Cancer; 2022 Nov; 61(11):662-669. PubMed ID: 35655408 [TBL] [Abstract][Full Text] [Related]
40. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis. Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]